Haemonetics Corp.
HAE
Market Cap$3.29B
Close$
$195.70
198.7% upside
Current Fair Value
198.7% upsideUndervalued by 198.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.29 Billion |
|---|---|
| Enterprise Value | $4.20 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $2.32 |
| Beta | 0.43 |
| Outstanding Shares | 50,286,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 25.33 |
|---|---|
| PEG | 126.56 |
| Price to Sales | 2.43 |
| Price to Book Ratio | 3.64 |
| Enterprise Value to Revenue | 3.05 |
| Enterprise Value to EBIT | 20.34 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.35 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon